Harare to India for Cancer Treatment: A Zimbabwean Patient's Real Story, Costs & Journey 2025

What does travelling from Zimbabwe to India for cancer treatment actually look like? One patient's honest account — visa process, real costs (USD 15,500 total), Chennai hospital experience, and advice for Zimbabwean families considering the same journey.

This is Rutendo's story.

She has given permission for it to be told, with her name changed, because she wants other Zimbabwean families to have the information she did not have when she needed it most. Not a polished version. Not a brochure. The real version — the fear, the confusion, the moments when everything felt impossible, and the moments when it did not.

She was 47 when she was diagnosed with stage 2B breast cancer in October. By December, she was in Chennai. By the following April, she was home.

This is what happened in between.

---

October: The Diagnosis

Rutendo had noticed the lump in August. She had gone to a clinic in Harare in September. The biopsy results came back in early October.

Stage 2B breast cancer. HER2-positive. Her oncologist — a thorough, overworked man at Parirenyatwa Hospital — sat with her for forty minutes and explained everything. The staging. The biology. The treatment protocol that international guidelines recommended: neoadjuvant chemotherapy first, then surgery, then radiotherapy, then twelve months of trastuzumab.

Then he told her what was available.

Chemotherapy: yes, though the specific regimen he preferred had a drug that was intermittently out of stock. Surgery: yes, but there was a four-month waiting list for elective oncology procedures. Radiotherapy: uncertain — the machine had been functioning but had a history of breakdowns. Trastuzumab: not available in the public system. Private sourcing would cost approximately USD 1,800 per cycle for 17 cycles.

He did not tell her to go to India. He was careful, professional, and working within the system he had. But he answered her questions honestly when she asked them. And when she asked whether patients sometimes went abroad, he said yes — some do go to India, and they come back with good results.

She went home and told her husband, Farai.

---

The Two Weeks After Diagnosis: Research, Fear, and the First Phone Call

Farai is an accountant. When he is frightened, he makes spreadsheets.

He spent two weeks building a spreadsheet of every option. Private treatment in Zimbabwe — the costs were significant and still incomplete. South Africa — better equipped but still expensive, and the logistics of extended stays were complicated. United Kingdom — effectively impossible on their budget. India — the more he researched, the more it appeared on forums, in diaspora WhatsApp groups, in the stories of other Zimbabwean families.

He found a hospital in Chennai with an international patient department. He found another in Mumbai. He found a third in Hyderabad.

He sent the same email to all three: Rutendo's biopsy report, her staging summary, and a direct question — what would treatment cost, how long would it take, and what was the process?

Within 48 hours, all three hospitals had responded.

The responses were detailed. Each one included a preliminary treatment plan, a cost estimate broken into components, a timeline, and a contact name in the international patient department. One hospital — the Chennai one — followed up with a WhatsApp message the same evening asking whether they had any questions.

Farai updated his spreadsheet. The numbers were real. They were large. But they were not impossible.

They chose the Chennai hospital because of the speed of the response, the clarity of the cost breakdown, and because a man in Farai's church had an uncle who had been treated there for prostate cancer two years earlier and had nothing but good things to say.

---

November: Documents, Visa, and the Conversations Nobody Prepares You For

The hospital had asked for a specific set of documents: the original biopsy report, the histopathology with receptor status (confirming HER2-positive), the staging CT scan on a USB drive, blood test results from the past month, and a brief letter from her Harare oncologist summarising the diagnosis and proposed treatment.

Gathering these took eleven days. The CT scan images required a specific request to the imaging department at Parirenyatwa. The letter from the oncologist required a formal application that took four days to process. The biopsy report original had to be collected in person.

This is worth knowing in advance: gathering your medical records in Zimbabwe takes longer than you expect. Start the moment you make the decision to seek care abroad. Do not wait until the visa is ready.

The hospital issued the invitation letter within three days of receiving the documents. It came by email — a formal letter on hospital letterhead confirming that Rutendo Moyo was a registered patient scheduled to commence treatment and requesting the Indian High Commission issue a medical visa.

The e-Medical Visa application was completed online. The documents required were: passport, the hospital invitation letter, two recent passport-sized photographs, and a bank statement showing sufficient funds. Farai completed the application on a Thursday evening. The visa was approved the following Tuesday — five days including the weekend.

The companion visa — for Farai, who would accompany her — was issued at the same time.

Total visa cost: approximately USD 60 for both.

---

The Conversations Nobody Prepares You For

While the paperwork was being assembled, there were other conversations happening.

With her mother, who had heard about a woman from their neighbourhood who had gone to South Africa for cancer treatment and come back in a coffin. Who needed several evenings of quiet conversation before she understood that going to India was not giving up — it was the opposite.

With their two children — a son of 19 and a daughter of 16. Who were told clearly and honestly what was happening, what the treatment involved, and what the plan was. Who surprised both their parents with their steadiness.

With Rutendo's employer, who needed to understand that she would be away for approximately two months and that this was a medical necessity. Her employer was, she says, kinder than she had expected.

With extended family, about money. This was the hardest conversation of all.

The treatment estimate from Chennai was USD 11,400 for the complete protocol: neoadjuvant chemotherapy, surgery (modified radical mastectomy — breast-conserving surgery was discussed but not recommended at her stage), and the first portion of radiotherapy. Trastuzumab would begin in Chennai and continue in Zimbabwe if a private source could be arranged, or would be completed in India on a return visit.

Travel — return flights for two from Harare via Johannesburg to Chennai — was approximately USD 1,800.

Accommodation — a service apartment two kilometres from the hospital, arranged by the hospital's international patient team — was USD 28 per night.

Over two months, the total accommodation cost was approximately USD 1,680.

Food and daily living: approximately USD 600.

Total cost for the complete India component of Rutendo's treatment: approximately USD 15,500.

This was assembled through: Farai's savings, a contribution from Rutendo's brother in the United Kingdom diaspora, a personal loan from a close family friend, and — after some research — a partial advance from Rutendo's employer against her medical aid.

It was not easy. It required the kind of financial mobilisation that only a family facing a genuine crisis can summon. But it was possible.

---

The Journey: Harare to Chennai

They flew Air Zimbabwe to Johannesburg on a Sunday evening. In Johannesburg, they had a six-hour layover at OR Tambo — long enough to eat properly and sleep briefly in the transit area. Then IndiGo Airlines to Chennai via a brief stop. Total journey time from Harare to Chennai: approximately 19 hours.

Rutendo says the journey was surreal. She had never left Zimbabwe before, except once to Zambia for a wedding. She was flying to a country she had never visited, to be treated by doctors she had never met, for a disease she had only known about for six weeks.

She was terrified.

She was also, she says, more determined than she had ever been about anything in her life.

---

The First Week in Chennai: Arrival, Assessment, and the Beginning

A driver from the hospital met them at Chennai airport, holding a sign with Rutendo's name. This small detail — being expected, being met — mattered more than either of them had anticipated. After months of navigating an indifferent system in Zimbabwe, being received with organisation and kindness was, Rutendo says, almost overwhelming.

The service apartment was clean, simply furnished, and ten minutes from the hospital by auto-rickshaw. The hospital had provided a printed information pack: nearby restaurants, pharmacy locations, the international patient department contact number, emergency contacts.

The first appointment — with her assigned oncologist, a breast cancer specialist — was the following morning.

He had read her file. He knew her biopsy results. He knew her receptor status. When they sat down, he did not begin by asking her to repeat her history — he began by confirming his understanding of it and asking whether she had questions.

She had twenty-three questions. She had written them down on a list. He answered all of them.

The treatment plan was confirmed: four cycles of neoadjuvant chemotherapy (EC-T protocol — epirubicin, cyclophosphamide, then paclitaxel), followed by surgery, followed by radiotherapy beginning three to four weeks post-surgery. Trastuzumab would commence alongside chemotherapy and continue for twelve months.

A port was placed for chemotherapy two days later. Chemotherapy began on the Thursday — eleven days after they had landed.

---

Weeks Two Through Eight: Treatment, Adaptation, and Unexpected Grace

Chemotherapy was hard. This is not minimised here. The first cycle hit Rutendo harder than she had expected — the nausea, the fatigue, the hair loss that began in week three. She had known intellectually that these things would happen. Living them was different.

What was not hard — or rather, what was harder than she had expected to be easier — was the support structure.

The nursing staff knew her by name within a week. The oncology nurses who administered chemotherapy remembered which side effects she had reported from the previous cycle and asked specifically about them. A hospital nutritionist visited twice and helped her understand what to eat to manage nausea. A counsellor from the psycho-oncology department visited once a week.

When Rutendo mentioned, in passing, that she was struggling to call her children because of the time difference and the cost of international calls, a nurse told her about a WhatsApp calling plan that cost almost nothing and worked reliably on the hospital wi-fi.

These are small things. They are also the things that make a frightening experience survivable.

Farai, meanwhile, was doing what accountants do. He had found a good local restaurant run by a South Indian family who recognised within two days that he was a foreigner navigating unfamiliar food and took it upon themselves to explain the menu slowly and point him toward the dishes most likely to agree with his wife's nausea. He had found a pharmacy that stocked the anti-nausea medication at a fraction of the hospital dispensary price. He had found a park a fifteen-minute walk away where they went in the evenings when Rutendo had the energy.

Life, even in the middle of treatment in a foreign country, had found its shape.

---

The Surgery

After four chemotherapy cycles, Rutendo's imaging showed a significant response — the tumour had reduced substantially. Her oncologist confirmed the treatment was working.

Surgery was scheduled three weeks after the final chemotherapy cycle, to allow recovery.

The modified radical mastectomy took approximately three hours. Rutendo was in the hospital for four days. She describes waking from surgery and being told by her oncologist, who visited that evening, that the surgical margins were clear — that they had removed everything they could see.

She cried. Farai cried. The oncologist, she says, seemed quietly pleased in the restrained way of a person who has delivered good news many times and has never quite stopped meaning it.

Pathology confirmed a good response to neoadjuvant chemotherapy. The subsequent treatment decision — whether additional chemotherapy was needed — was discussed at the hospital's multidisciplinary tumour board, a meeting of surgeons, oncologists, radiologists, and pathologists who review complex cases together. The recommendation was to proceed with radiotherapy and continue trastuzumab.

---

Radiotherapy and the Final Weeks

Radiotherapy — 25 fractions over five weeks — began four weeks after surgery. It was, relative to chemotherapy, more manageable. The fatigue accumulated. The skin over the treated area became sore and tender. But the sessions were short, the scheduling was precise, and the machine — a modern linear accelerator — worked every day.

Rutendo had been told in Harare that the radiotherapy machine might not be available for months. In Chennai, her 25 fractions were completed in exactly five weeks, as scheduled.

By the end of week seven, treatment was complete. The discharge summary — a comprehensive document covering every aspect of her treatment, pathology, drug protocols, and follow-up schedule — was prepared over two days and presented to her at a final consultation with her oncologist.

He reviewed the follow-up plan in detail: trastuzumab to continue (arrangements had been made for private sourcing in Zimbabwe for the remaining cycles), blood tests every three months, imaging at six months and one year, and the specific symptoms that should prompt an urgent return visit.

He also gave her his direct contact details and told her to email if she had questions. She has used that email address three times since returning to Zimbabwe. He has responded to each message within 48 hours.

---

Coming Home

They flew home on a Thursday in April — approximately twenty-two weeks after the diagnosis, fifteen weeks after arriving in Chennai.

At Harare airport, Rutendo's mother, children, and three close friends were waiting. Her mother had brought food. Her daughter had made a sign.

Rutendo says the moment she walked out of arrivals and saw her daughter's sign — hand-drawn, decorated with flowers, reading simply Welcome Home Mama — was the moment she felt, for the first time since October, that everything was going to be all right.

Not certain. Not guaranteed. Cancer does not offer guarantees. But possible.

Possible was enough.

---

What Rutendo and Farai Would Tell You

They have been asked, many times since returning, what advice they would give to Zimbabwean families facing the same decision. Here, in their own words, is what they say.

Start the research earlier than you think you need to. The moment a serious diagnosis is made — not after the second opinion, not after the waiting list comes back with a bad number — start researching international options. Information gathering costs nothing and losing weeks costs a great deal.

Gather your medical documents immediately and methodically. Create a folder — physical and digital — with every piece of paper from every appointment. In Zimbabwe, getting records re-issued takes time you may not have.

The visa is simpler than you think. Do not let fear of the administrative process delay the decision. The e-Medical Visa took five days. It was not complicated. The hospital walks you through it.

Budget honestly, including the hidden costs. The treatment estimate is real, but add travel, accommodation, food, medicines from local pharmacies, and small unexpected costs. Then add 15% on top as a buffer. Financial surprises mid-treatment are stressful in a way that is hard to describe.

Lean on your community. The money came from many places — savings, diaspora family, a friend, an employer. No single source could have covered it alone. Be honest with people about what you need. Most people want to help when they understand what is actually required.

The fear of going is worse than being there. The anticipation — the strangeness of it, the distance, the foreignness — is the hardest part. Once you are there, once you have met the team and begun the process, it becomes simply the next thing that needs to happen. And you do it.

---

One Year Later

Rutendo's six-month scan showed no evidence of disease. Her twelve-month scan, taken three weeks before this article was published, showed the same.

She is completing her final trastuzumab cycles, sourced privately in Harare. She is back at work. Her hair has grown back. She takes tamoxifen every morning.

She still answers messages from Zimbabwean families who have found her through her church, through friends of friends, through the diaspora networks that carry these stories quietly from one family to the next.

She answers every one.

She tells them: it is scary. It costs money. It is far from home. And it is worth it.

[If you are a Zimbabwean family facing a cancer diagnosis and considering treatment in India, our patient support team is available for a free consultation →](https://treatcancerinindia.com/cancer-treatment-india-for-zimbabwe)

For specific cancer types, you may also find these helpful:

• [Breast cancer treatment in India for Zimbabwean patients →](https://treatcancerinindia.com/breast-cancer-treatment-india-for-zimbabwe)
• [Cervical cancer treatment in India for Zimbabweans →](https://treatcancerinindia.com/cervical-cancer-treatment-india-for-zimbabwe)
• [Prostate cancer treatment in India for Zimbabwean patients →](https://treatcancerinindia.com/prostate-cancer-treatment-india-for-zimbabwe)
• [Blood cancer treatment in India for Zimbabwean patients →](https://treatcancerinindia.com/blood-cancer-treatment-india-for-zimbabwe)